Question
Will tirzepatide be approved for the treatment of obesity by the FDA or EMA before 2025?
Resolved:YesTotal Forecasters36
Community Prediction
80%
(69% - 90%)
Make a Prediction
Did this actually happen?Yes
Community Peer Score
1.3
Authors:
Opened:Nov 24, 2021
Closes:Dec 31, 2024
Resolves:Dec 31, 2024
Spot Scoring Time:Nov 26, 2021
Learn more about Metaculus NewsMatch
Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?
45%
Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?
80.8%
Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?
63%
Authors:
Opened:Nov 24, 2021
Closes:Dec 31, 2024
Resolves:Dec 31, 2024
Spot Scoring Time:Nov 26, 2021
Learn more about Metaculus NewsMatch
Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?
45%
Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?
80.8%
Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?
63%